Gene Termination Signal Loss Linked to Cardiac Defects
The study reveals how faulty polyadenylation triggers harmful fusion transcripts in experimental mouse models.
Updated on Oct. 15, 2026 in Life Sciences
Researchers have used mouse models to determine how polyadenylation signals regulate transcriptional termination at the Atf4 locus. The study demonstrates that loss of this signal triggers the creation of a fusion transcript, resulting in cardiac defects.
Why it matters
Understanding the fidelity of transcriptional termination is critical to uncovering how genetic errors lead to organ-level pathologies. This research clarifies the role of canonical polyadenylation signals in preventing harmful downstream transcriptional readthrough.
Loss of the polyadenylation signal (PAS) permits the use of a cryptic intragenic PAS within exon 3, leading to a prematurely terminated transcript. This enables the formation of an Atf4-Cacna1i fusion transcript that actively suppresses Rps19bp1.
The players
Atf4 locus
A genetic region encoding a transcription factor involved in cellular stress responses.
Cacna1i
A gene involved in calcium channel function that forms a fusion transcript with Atf4 in this study.
Rps19bp1
A regulatory protein suppressed by the Atf4-Cacna1i fusion transcript.
The details
Researchers created complementary mouse models to isolate PAS function at the Atf4 locus, specifically testing deletions of the coding sequence (CDS) and the PAS. The Atf4 ΔCDS + ΔPAS allele forces transcriptional readthrough, where the molecular machinery fails to stop at the end of a gene and continues into neighboring DNA. This results in the fusion transcript Atf4-Cacna1i. These findings illustrate the essential role of the canonical PAS in ensuring termination fidelity and preventing the production of aberrant, pathological transcripts.
The Tech Race
This study refines the understanding of gene termination mechanisms, which is essential for ongoing efforts to map the functional consequences of the transcriptome. These findings mark a departure from purely descriptive genomics by proving that specific PAS deletions lead to predictable cardiac pathology.
This research is currently at the stage of foundational laboratory discovery in mouse models. It does not yet offer direct clinical applications or medical diagnostics for human heart conditions.
The takeaway
Researchers have confirmed that the loss of a single polyadenylation signal can trigger fusion transcripts linked to organ-wide structural defects. Future studies will need to identify whether similar cryptic termination events occur in human cardiac patients with undefined genetic conditions.
Further reading
For broader context on how gene expression regulation impacts health, visit Life Sciences.
More information
View the peer-reviewed research article for detailed data on the Atf4 locus models.
Source note: This article includes information reported by Nature.
